IP Library Granted Patent US 9,849,296
Granted Patent B2
US 9,849,296 · App. 15/476,716 · Granted Dec 26, 2017

Directly integrated feedthrough to implantable medical device housing

Inventors: Jacob Markham (Vadnais Heights, MN); Ulrich Hausch (Frankfurt, DE)
Assignee: Heraeus Deutschland GmbH & Co. KG
A61N1/3754B23K1/0016C04B37/026C04B2237/125C04B2237/403C04B2237/708
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,849,296
App. No.
15/476,716
Granted
Dec 26, 2017
Kind
B2
Abstract

One aspect provides an implantable medical device with a housing having an opening with an opening width. A feedthrough is provided, including an insulator having a bottom surface and side surfaces and having an insulator width between opposing side surfaces that is greater than the opening width. A sinter joint is between at least one of the bottom surface, top surface, and side surfaces of the insulator and the housing which hermetically seals the insulator to the housing without an intervening ferrule.

Claims (25)

1. An implantable medical device comprising:

a housing having an opening with an opening width;

a feedthrough including an insulator having a bottom surface facing an interior space within the housing, a top surface facing away from the interior space, and opposing first and second side surfaces and having an insulator width between opposing side surfaces that is greater than the opening width; and

a sinter joint between at least one of the bottom surface, top surface, and side surfaces of the insulator and the housing which hermetically seals the insulator directly to the housing without an intervening ferrule, braze or weld;

wherein the housing comprises titanium, and wherein the titanium has an average grain size of not more than 100 μm.

2. The implantable medical device of claim 1 , wherein the sinter joint comprises one of gold, palladium, iridium, and alloy combinations thereof.

3. The implantable medical device of claim 1 , wherein a surface of the insulator at the sinter includes a metallized layer.

4. The implantable medical device of claim 1 , wherein the sinter joint has a density in a range from 90 to 99 percent of a biocompatible bonding material.

5. The implantable medical device of claim 1 , wherein a width of the sinter joint between the insulator and the housing along a perimeter of the housing opening is at least one quarter a width of the insulator at its widest point.

6. The implantable medical device of claim 1 , wherein a plane normal to the opening passes through the housing, the sinter joint, and the insulator.

7. The implantable medical device of claim 1 , wherein the sinter joint has a thickness in a direction perpendicular to the housing in a range from 25 to 200 μm.

8. The implantable medical device of claim 1 , wherein the housing includes a flange which forms a recess that extends toward the interior space and about the opening, and the insulator being positioned at least partially within the recess and over the opening.

9. The implantable medical device of claim 8 , wherein the flange includes first and second downwardly angled portions that forms opposing sidewalls of the recess and wherein opposing side surfaces of the insulator are respectively sealed to the opposing sidewalls of the recess.

10. An implantable medical device comprising:

a housing having an opening with an opening width;

a feedthrough including an insulator having a bottom surface facing an interior space within the housing, a top surface facing away from the interior space, and opposing first and second side surfaces and having an insulator width between opposing side surfaces that is greater than the opening width; and

a sinter joint between at least one of the bottom surface, top surface, and side surfaces of the insulator and the housing which hermetically seals the insulator to the housing without an intervening ferrule;

wherein the housing comprises titanium, and wherein the titanium has an average grain size of not more than 100 μm.

11. The implantable medical device of claim 10 , wherein the sinter joint comprises gold.

12. The implantable medical device of claim 10 , wherein in the sinter joint comprises one of gold, palladium, iridium, and alloy combinations thereof.

13. The implantable medical device of claim 10 , wherein the sinter joint has a density in a range from 90 to 99 percent of a biocompatible bonding material.

14. The implantable medical device of claim 10 , wherein a width of the sinter joint between the insulator and the housing along a perimeter of the housing opening is at least one quarter a width of the insulator at its widest point.

15. The implantable medical device of claim 10 , wherein a plane normal to the opening passes through the housing, the sinter joint, and the insulator.

16. The implantable medical device of claim 10 , wherein the sinter joint has a thickness in a direction perpendicular to the housing in a range from 25 to 200 μm.

17. The implantable medical device of claim 10 , wherein the housing includes a flange which forms a recess that extends toward the interior space and about the opening, and the insulator being positioned at least partially within the recess and over the opening.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2024
From: HERAEUS DEUTSCHLAND GMBH & CO. KG
To: HERAEUS MEDEVIO GMBH & CO. KG
Reel/Frame 068189/0526 →
MERGER Recorded Jun 28, 2024
From: HERAEUS PRECIOUS METALS GMBH & CO. KG
To: HERAEUS DEUTSCHLAND GMBH & CO. KG
Reel/Frame 068377/0925 →
Continuity (2)
Division 14104653 · Dec 12, 2013
Related Publication 20170203107A1 · Jul 20, 2017